Rabbit Recombinant Monoclonal NCAP antibody. Carrier free. Suitable for I-ELISA, ICC/IF, WB and reacts with Recombinant full length protein - Influenza B, Transfected cell line - Influenza B samples.
pH: 7.4
Constituents: 100% PBS
I-ELISA | ICC/IF | WB | |
---|---|---|---|
Influenza B | Not recommended | Not recommended | Predicted |
Purified native protein - Influenza A | Not recommended | Not recommended | Not recommended |
Recombinant full length protein - Influenza B | Tested | Not recommended | Not recommended |
Transfected cell line - Influenza B | Not recommended | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Influenza B | Dilution info 1 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Purified native protein - Influenza A, Influenza B, Transfected cell line - Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell line - Influenza B | Dilution info 1/100.00000 - 1/2000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B, Purified native protein - Influenza A, Recombinant full length protein - Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell line - Influenza B | Dilution info 1/1000.00000 - 1/50000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Purified native protein - Influenza A, Recombinant full length protein - Influenza B | Dilution info - | Notes - |
Influenza B Virus NP, NP, Nucleocapsid protein, Nucleoprotein, Protein N
Rabbit Recombinant Monoclonal NCAP antibody. Carrier free. Suitable for I-ELISA, ICC/IF, WB and reacts with Recombinant full length protein - Influenza B, Transfected cell line - Influenza B samples.
pH: 7.4
Constituents: 100% PBS
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
The Influenza B Virus Nucleoprotein often known as NP or flu B NP is an essential structural protein with a molecular weight of approximately 56 kDa. It plays a role in the influenza B virus lifecycle by encapsidating the viral RNA forming the ribonucleoprotein complex important for viral replication and transcription. This protein expresses in the host cell's cytoplasm and nucleus facilitating the export of vRNPs from the nucleus.
The ribonucleoprotein complex formation involves nucleoproteins assembling with the viral RNA and polymerase subunits securing the genome for replication and transcription. NP interacts with both the polymerase basic 2 (PB2) and polymerase acidic (PA) proteins forming a vital part of the complex. This interaction allows the viral RNA to maintain its structure and function effectively during the virus infection cycle aiding both Influenza A and B viruses.
NP participates in the viral replication pathway supporting the influenza virus propagation in infected cells. It associates closely with viral RNA polymerases and is integral to the transcription and replication of the viral RNA genome. Other key proteins involved in these pathways include the polymerase basic 1 (PB1) protein essential for synthesizing viral mRNA and the matrix protein (M1) which aids in vRNA encapsidation and budding.
NP relates closely to influenza B infections contributing to the clinical symptoms of flu B such as fever and respiratory issues. This protein is also a potential target for vaccine and therapeutic development against influenza B. NP shares a connection with the M2 protein another target in antiviral strategies given its role in proton channel activity and viral uncoating. Understanding NP's role can guide the creation of flu B antibodies and influenza A and B antibodies to reduce disease severity or prevent flu infections.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Influenza B viral lysates (1 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Influenza B virus Nucleoprotein antibody [HL1073] (ab308414) diluted at 1/1000. A HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.
All lanes: Western blot - Anti-Influenza B virus Nucleoprotein antibody [HL1073] (ab308414) at 1/1000 dilution
Lane 1: B/Brisbane/33/08 viral lysate at 1 µg
Lane 2: B/Florida/02/06 viral lysate at 1 µg
Lane 3: B/Florida/04/06 viral lysate at 1 µg
Lane 4: B/Florida/07/04 viral lysate at 1 µg
Lane 5: B/Malaysia/2506/04 viral lysate at 1 µg
Lane 6: B/Massachusetts/2/12 viral lysate at 1 µg
Lane 7: B/Panama/45/90 viral lysate at 1 µg
Lane 8: B/Wisconsin/1/10 viral lysate at 1 µg
Lane 9: B/Lee/40 viral lysate at 1 µg
All lanes: HRP-conjugated anti-rabbit IgG antibody
For immunofluorescence analysis, Influenza A and B Virus infected cells slide were permeabilized for detection of Influenza B virus Nucleoprotein using ab308414 at 1/100 dilution (green).
Non-transfected (–) and transfected (+) HEK293T whole cell lysate (30 μg) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Influenza B virus Nucleoprotein antibody [HL1073] (ab308414) diluted at 1/50000. A HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.
All lanes: Western blot - Anti-Influenza B virus Nucleoprotein antibody [HL1073] (ab308414) at 1/50000 dilution
Lane 1: Non-transfected (–) HEK293T whole cell lysate at 30 µg
Lane 2: Transfected (+) HEK293T whole cell lysate at 30 µg
All lanes: HRP-conjugated anti-rabbit IgG antibody
Indirect ELISA analysis performed by coating plate with recombinant full-length Influenza B virus NP (nucleoprotein) protein, DDDDK tag (50 ng). Coated protein was probed with Influenza B virus Nucleoprotein antibody [HL1073] (ab308414) (20000-4.77*10-3 pM). Rabbit IgG antibody (HRP) (1/10000) was used to detect bound primary antibody.
Indirect ELISA analysis performed by coating plate with viral lysate derived from different strains of Influenza A virus (i.e., A/California/07/09 (H1N1)) and Influenza B virus (i.e., B/Brisbane/33/08; B/Florida/02/06; B/Florida/04/06; B/Florida/07/04; B/Malaysia/2506/04; B/Massachusetts/2/12; B/Panama/45/90; B/Wisconsin/1/10; B/Lee/40) (1-0.2 μg). Coated protein was probed with Influenza B virus Nucleoprotein antibody [HL1073] (ab308414) (1 μg/mL). Rabbit IgG antibody (HRP) (1/10000) was used to detect bound primary antibody.
For immunofluorescence analysis, mock and transfected HEK293T cells were fixed in 4% paraformaldehyde at room temperature for 15 minutes and permeabilized for detection of Influenza B virus Nucleoprotein using ab308414 at 1/2000 dilution (green).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com